☆venBio Partners LLC
Quality Q
0.470
AUM ($M)
519
Positions
7
Turnover
0.35
Top-10 wt
100%
Herfindahl
0.242
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 8 positions · portfolio value $519M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆PHVS funds › | PHARVARIS N V | ADD | — | 30.9% | -15.8% | 160.6 | 4,643,430 | +4,126 | 5 | — |
| ☆PBLS funds › | PARABILIS MEDICINES INC | NEW | — | 27.8% | +27.8% | 144.1 | 5,266,697 | +5,266,697 | 1 | — |
| ☆ALMS funds › | ALUMIS INC | HOLD | — | 24.5% | -11.0% | 127.4 | 4,528,408 | +0 | 5 | — |
| ☆ACHV funds › | ACHIEVE LIFE SCIENCE INC | NEW | — | 7.4% | +7.4% | 38.6 | 5,914,720 | +5,914,720 | 1 | — |
| ☆ALXO funds › | ALX ONCOLOGY HLDGS INC | HOLD | Common Stock | 5.1% | -4.1% | 26.7 | 12,884,638 | +0 | 5 | — |
| ☆HRMY funds › | HARMONY BIOSCIENCES HLDGS IN | TRIM | — | 3.3% | -1.6% | 17.2 | 472,194 | -17,000 | 5 | — |
| ☆LYEL funds › | LYELL IMMUNOPHARMA INC | HOLD | — | 0.9% | -1.5% | 4.7 | 337,697 | +0 | 5 | — |
| ☆ARTV funds › | ARTIVA BIOTHERAPEUTICS INC | EXIT | — | 0.0% | -1.2% | 0.0 | 0 | -531,337 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 519 | 7 | 0.35 | 100% | 0.242 | 0.471 | — | in |
| 2026Q1 | 281 | 6 | 0.19 | 100% | 0.356 | 0.716 | — | in |
| 2025Q4 | 216 | 6 | 0.12 | 100% | 0.410 | 0.761 | — | in |
| 2025Q3 | 176 | 6 | 0.08 | 100% | 0.460 | 0.800 | — | in |
| 2025Q2 | 115 | 6 | 0.15 | 100% | 0.468 | 0.651 | — | entered |
| 2025Q1 | 124 | 7 | 0.00 | 100% | 0.344 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status